U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. GNMART INC Issues Voluntary Nationwide Recall of Force Forever Due to Undeclared Drug Ingredients Diclofenac and Dexamethasone
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

GNMART INC Issues Voluntary Nationwide Recall of Force Forever Due to Undeclared Drug Ingredients Diclofenac and Dexamethasone

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Dietary Supplements
Reason for Announcement:
Recall Reason Description
Product contains undeclared diclofenac and dexamethasone
Company Name:
GNMART Inc
Brand Name:
Brand Name(s)
Force Forever
Product Description:
Product Description
Dietary Supplement

Company Announcement

FOR IMMEDIATE RELEASE – 12/12/2024, Dover Plains, NY, GNMART INC is voluntarily recalling all lots of Force Forever for joint Pain, 60 Tablets packaged in a white plastic bottle with a red cap, labeled as "FORCE FOREVER.", to the consumer level. FDA analysis has found product to contain undeclared Diclofenac and Dexamethasone.

Risk Statement: Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Corticosteroid use can impair a person’s ability to fight infections and can cause high blood sugar levels, muscle injuries and psychiatric problems. GNMart has not received any reports of adverse events related to this recall.

The product is used as a dietary supplement for joint pain and is packaged in bottles with 60 tablets. The affected product includes all lots and expiration date: 03/27/2030. The product was distributed nationwide via the internet at gnmart.com.

GNMart is notifying its customers by email and is arranging for return of all recalled products. Consumers that have product which is being recalled should stop using and return to place of purchase. Consumers may return the products to the address below via mail:

GNMart, Inc., 15 Sawmill Ln, Dover Plains, NY 12522

Consumers with questions regarding this recall can contact GNMart at info@gnmart.com by e-mail 24 hours a day and can expect a 24 to 48-hour response time, Monday - Friday, 9am-5pm EST.. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Link to FDA Advisory


Company Contact Information

Consumers:
info@gnmart.com

Product Photos

Back to Top